[Skip to Navigation]
Sign In
Views 259
Citations 0
Comment & Response
September 2018

Clarification of the FDA Accelerated Agnostic Approval of Pembrolizumab and the Opportunities Arising From the Required Confirmatory Studies

Author Affiliations
  • 1Oncology Division, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina
JAMA Oncol. 2018;4(9):1299-1300. doi:10.1001/jamaoncol.2018.1709
Add or change institution